XML 25 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]      
Research and development expenses, net $ 8,638 $ 4,089 $ 904
Marketing and sales 987 1,015 224
General and administrative 3,696 3,753 2,627
Operating loss 13,321 8,857 3,755
Equity in net loss (gain) of an affiliated company 2,905 (156) 108
Financial expenses (income), net (1,569) 7,241 (1,950)
Net Loss $ 14,657 $ 15,942 $ 1,913
Basic and diluted loss per share (in USD) $ (0.12) $ (0.17) $ (0.03)
Weighted average number of shares outstanding used in computing basic and diluted loss per share - in thousands 120,612 94,401 67,311